Early LA Venting During Venoaterial ECMO Support

Status Completed

Clinical Trial Summary

The EVOLVE-ECMO(Early Left Atrial Venting Versus Conventional Treatment For Left VEntricular Decompression During Venoarterial ExtraCorporeal Membrane Oxygenation Support) study is a randomized controlled trial to evaluate the prognostic effect of early LA venting(when detect B-line on serial lung ultrasound) on weaning VA-ECMO support in refractory CS who receive VA-ECMO support. The aim of EVOLVE-ECMO trial is to test the hypothesis that early LA venting would result in a significant reduction in failure of weaning ECMO support in refractory CS.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cardiogenic Shock
Extracorporeal Membrane Oxygenation Support
Pulmonary Edema
Refractory Pulmonary Edema
Shock, Cardiogenic

Clinical Trial Details

NCT number	NCT03740711
Study type	Interventional
Source	Asan Medical Center
Contact
Status	Completed
Phase	N/A
Start date	December 12, 2018
Completion date	August 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03283995` - Hemodynamic Assessment in Cardiogenic Shock Regarding the Etiology
Active, not recruiting	`NCT04325035` - The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock	Phase 2
Active, not recruiting	`NCT05100836` - SURPASS Impella 5.5 Study
Not yet recruiting	`NCT05106491` - Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients	N/A
Completed	`NCT02301819` - ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock	N/A
Completed	`NCT01367743` - Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock	Phase 4
Recruiting	`NCT05728359` - Genomic Determinants of Outcome in Cardiogenic Shock
Recruiting	`NCT05699005` - Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO	Phase 1
Not yet recruiting	`NCT06338345` - Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients	N/A
Completed	`NCT03436641` - Microcirculation in Cardiogenic Shock
Recruiting	`NCT03313687` - SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
Recruiting	`NCT05506449` - The RECOVER IV Trial	N/A
Completed	`NCT04144660` - "Treatment Use of ECMO In Pregnancy or Peripartum Patient."
Completed	`NCT04548739` - Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)
Recruiting	`NCT04141410` - Global Longitudinal Strain Assessment in Cardiogenic Shock During Sepsis
Not yet recruiting	`NCT05879276` - Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.	Phase 3
Enrolling by invitation	`NCT05570864` - Score TO Predict SHOCK - STOP SHOCK
Completed	`NCT02591771` - Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock	Phase 2
Terminated	`NCT02279979` - Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial	N/A
Completed	`NCT01374867` - CardShock Study and Registry	N/A